Lung metastases share common immune features regardless of primary tumor origin
Top Cited Papers
Open Access
- 1 January 2020
- journal article
- research article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 8 (1), e000491
- https://doi.org/10.1136/jitc-2019-000491
Abstract
Background Only certain disseminated cells are able to grow in secondary organs to create a metastatic tumor. Under the hypothesis that the immune microenvironment of the host tissue may play an important role in this process, we have categorized metastatic samples based on their immune features. Methods Gene expression data of metastatic samples (n=374) from four secondary sites (brain, bone, liver and lung) were used to characterize samples based on their immune and stromal infiltration using gene signatures and cell quantification tools. A clustering analysis was done that separated metastatic samples into three different immune categories: high, medium and low. Results Significant differences were found between the immune profiles of samples metastasizing in distinct organs. Metastases in lung showed a higher immunogenic score than metastases in brain, liver or bone, regardless of their primary site of origin. Also, they preferentially clustered in the high immune group. Samples in this cluster exhibited a clear inflammatory phenotype, higher levels of immune infiltrate, overexpression of programmed death-ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) pathways and upregulation of genes predicting clinical response to programmed cell death protein 1 (PD-1) blockade (T-cell inflammatory signature). A decision tree algorithm was used to select CD74 as a biomarker that identify samples belonging to this high-immune subtype of metastases, having specificity of 0.96 and sensitivity of 1. Conclusions We have found a group of lung-enriched metastases showing an inflammatory phenotype susceptible to be treated with immunotherapy.Funding Information
- Agency for Management of University and Research Grants (AGAUR) of the Catalan Government (2017SGR723)
This publication has 44 references indexed in Scilit:
- The Inflammatory Chemokine CCL5 and Cancer ProgressionMediators of Inflammation, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Inhaled corticosteroid use and risks of lung cancer and laryngeal cancerRespiratory Medicine, 2013
- Tumour-associated macrophages and cancerCurrent Opinion in Pharmacology, 2013
- Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor OriginClinical Cancer Research, 2013
- Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungsOncogene, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- The secret second life of an innocent chaperone: the story of CD74 and B cell/chronic lymphocytic leukemia cell survivalLeukemia & Lymphoma, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005